Bio-Gate AG (FRA:BIG)

Market Cap	4.57M -38.2%
Revenue (ttm)	6.88M -2.3%
Net Income	-1.32M
EPS	n/a
Shares Out	2.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	2.180
Previous Close	2.340
Day's Range	2.180 - 2.240
52-Week Range	2.060 - 4.625
Beta	0.09
Analysts	Buy
Price Target	10.48 (+367.86%)
Est. Earnings	Dec 10, 2026

About Bio-Gate AG

Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an antimicrobial and antiviral additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is based in Nuremberg, Germany.

• Industry: Miscellaneous Chemical Products
• Founded: 2005
• Employees: 51
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BIG

Financial Performance

In 2025, Bio-Gate AG's revenue was 7.74 million, an increase of 9.15% compared to the previous year's 7.09 million. Losses were -1.16 million, -28.16% less than in 2024.

Analyst Summary

According to 3 analysts, the average rating for BIG stock is "Buy." The 12-month stock price target is €10.48, which is an increase of 367.86% from the latest price.

Price Target

€10.48

(367.86% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 30, 2026

Data Sources Report a data error